Clinical Trial Update: Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the combination of Decitabine and Temozolomide in metastatic melanoma (Phase 1/2) with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Decitabine (Decitabine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Hussein Tawbi | Conditions: Malignant Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-10-03